ERBB2 and breast cancer: In conclusion, p140Cap expression associates with reduced risk of metastasis (and death from cancer), in the ERBB2-amplified subgroup of breast cancer patients, arguing for a possible role of p140Cap in counteracting the migratory and/or metastatic ability of ERBB2-amplified tumour cells.